Japan's Sumitomo to establish regenerative medicine and cell therapy joint venture
Japan | News | 0 Comment | 20 Dec, 2024
Japan's Sumitomo Chemical Co. and Sumitomo Pharma have studied restructuring measures to accelerate the development of r...Read more
Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan
Japan | News | 0 Comment | 18 Dec, 2024
Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...Read more
Japan's Shimadzu develops platform to support gene therapy manufacturing
Japan | News | 0 Comment | 17 Dec, 2024
Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...Read more
Eisai Subsidiary inks €117 M deal for schizophrenia treatment in Japan and other Asian territories
Japan | News | 0 Comment | 16 Dec, 2024
Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with dise...Read more
TMC Japan BioBridge to provide Japanese healthcare innovators path to enter US market
Japan | News | 0 Comment | 10 Dec, 2024
Texas Medical Center (TMC), in the US, in partnership with Japan-based organisations Mitsui Fudosan Co. and&nb...Read more
Israel's Teva Pharma to divest business venture in Japan
Japan | News | 0 Comment | 06 Dec, 2024
Israel-based Teva Pharmaceutical Industries has entered into an agreement with JKI, established by the fund managed and ...Read more
SOHM, Inc. secures key patent in Japan for revolutionary gene editing technology
Japan | News | 0 Comment | 27 Nov, 2024
SOHM, Inc., a globally recognised pharmaceutical company focused on developing, manufacturing and distributing Generic, ...Read more
Eisai and Biogen Japan collaborate to lead dementia genomics R&D with NCNP in Japan
Japan | News | 0 Comment | 26 Nov, 2024
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...Read more
IIT Roorkee and Kyoto University open joint-research lab in Japan with focus on healthy ageing
Japan | News | 0 Comment | 25 Nov, 2024
The Indian Institute of Technology (IIT) Roorkee and Kyoto University have announce the inauguration of a joint research...Read more
Japan | News | 0 Comment | 23 Nov, 2024
US-based Kura Oncology, Inc. and Japanese pharmaceutical firm Kyowa Kirin have entered into a global strategic collabora...Read more
Singleron Joins Forces with TOMY Digital Biology to Transform Single Cell Analysis in Japan
Japan | News | 0 Comment | 20 Nov, 2024
Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with ...Read more
Kaken Pharmaceutical and Numab Therapeutics collaborate on inflammatory bowel disease treatment
Japan | News | 0 Comment | 15 Nov, 2024
Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...Read more
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan
Japan | News | 0 Comment | 18 Nov, 2024
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...Read more
Japan’s GHIT Fund invests $4 M to advance diagnostics and treatments for NTDs and malaria
Japan | News | 0 Comment | 08 Nov, 2024
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 mi...Read more
Inocras and Summit Pharma International Corp collaborate to transform clinical genomics in Japan
Japan | News | 0 Comment | 06 Nov, 2024
US-based Inocras Inc. and Summit Pharmaceuticals International Corporation have signed a Memorandum of understanding (Mo...Read more
Japan | News | 0 Comment | 05 Nov, 2024
Eisai Co. and Eisai’s corporate venture capital subsidiary, Eisai Innovation, Inc. have announced that Eisai Innov...Read more
Japan's Shimadzu Corp partners with US-based Sepragen marking entry into biopharma market
Japan | News | 0 Comment | 04 Nov, 2024
Japan-headquartered Shimadzu Corporation has announced its investment in US-based Sepragen Corporation, a leading compan...Read more
Japan's I Peace announces new iPSC lines to reduce immune rejection risk for US population
Japan | News | 0 Comment | 01 Nov, 2024
Japan-based GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell th...Read more